US 10195214
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted A61KA61K31/496A61K31/575
Quick answer
US patent 10195214 (Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors) held by Corcept Therapeutics Incorporated expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/496, A61K31/575, A61K31/7048, A61K45/06